ArticleParasite epidemiology and control2016
Spatial cluster analysis of Crimean-Congo hemorrhagic fever virus seroprevalence in humans, Greece.
Article in Parasite epidemiology and control, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 15 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
15 citing papers in PubMed, 23 citations in OpenAlex.
- Crimean-Congo hemorrhagic fever: An emerging threat in Europe.Virologica Sinica · 2026Review
- Article
- Seroprevalence of Crimean-Congo Hemorrhagic Fever Virus Infection in Humans and Domestic Ruminants, Democratic Republic of the Congo.Emerging infectious diseases · 2026Article
- Serological evaluation of Crimean-Congo Hemorrhagic fever in humans with High-Risk professional exposure and in residual sera collected in 2022-2023 across Corsica (France).One health (Amsterdam, Netherlands) · 2025Article
- Spatial-temporal variations of stroke mortality worldwide from 2000 to 2021.BMC public health · 2025Article
- Spatial analysis and risk mapping of Crimean-Congo hemorrhagic fever (CCHF) in Sub-saharan Africa.Scientific reports · 2025Article
- One health investigation following a cluster of Crimean-Congo haemorrhagic fever, North Macedonia, July to November 2023.Euro surveillance : bulletin Europeen sur les maladies transmissibles = European communicable disease bulletin · 2025Article
- Comprehensive Spatial-Temporal and Risk Factor Insights for Optimizing Livestock Anthrax Vaccination Strategies in Karnataka, India.Vaccines · 2024Article
- Seroprevalence of Crimean-Congo hemorrhagic fever virus in the population of Turkestan region.Le infezioni in medicina · 2024Article
- Quantifying the influence of climate, host and change in land-use patterns on occurrence of Crimean Congo Hemorrhagic Fever (CCHF) and development of spatial risk map for India.One health (Amsterdam, Netherlands) · 2023Article
- First serological evidence of Crimean-Congo haemorrhagic fever virus in transhumant bovines in Italy.Transboundary and emerging diseases · 2022Article
- History and classification of Aigai virus (formerly Crimean-Congo haemorrhagic fever virus genotype VI).The Journal of general virology · 2022Article
- Article
- Diagnostic tests for Crimean-Congo haemorrhagic fever: a widespread tickborne disease.BMJ global health · 2019Article
- Molecular detection of Crimean-Congo hemorrhagic fever virus in ticks, Greece, 2012-2014.Parasitology research · 2017Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors at 2 institutions in 1 country.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Crimean-Congo hemorrhagic fever (CCHF) is a viral disease transmitted to humans by bite of infected ticks or by direct contact with blood or tissues of viremic patients or livestock. The present cross-sectional meta-analysis study is based on previous data which have shown that the human CCHFV seroprevalence in specific regions of Greece is high (> 5%). In the absence of human cases, it has been suggested that a non- or low-pathogenic strain is circulating in the country causing asymptomatic infections. A spatial cluster analysis was performed to assess the geographical variations in CCHFV seropositivity and to identify the risk factors. The overall CCHFV seroprevalence is 3.8%, with significant rate difference between the eastern and western part of the country. Apart the risk factors described in previous studies (age, sex, tick bite, agropastoral activities), the altitude, the land cover type and the transitional woodland/shrub land per person, as well as the number of livestock per person, and specifically the number of goats, sheep and cattle per person, were shown to affect significantly the seroprevalence. Tick studies are needed to identify the circulating strains and unravel the mystery of CCHF epidemiology in Greece.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.